VIFOR PHARMA, INC.
REDWOOD CITY, CA

VIFOR PHARMA, INC., REDWOOD CITY
RELYPSA, INC.

Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening. We are focused on developing medicines that will change treatment paradigms. Relypsa was founded in October 2007 and is headquartered in Redwood City, Calif. In September 2016, Relypsa became a Vifor Pharma company. Learn more about Vifor Pharma Vifor Fresenius Medical Care Renal Pharma and Relypsa announce Submission of Marketing Authorisation Application Requesting European Approval of Patiromer for treatment of hyperkalemia Soho Flordis International signs an agreement for the acquisition of Potters and the Equazen(TM) brand portfolio from Vifor Pharma Vifor Fresenius Medical Care Renal Pharma: Expansion of product portfolio and establishment of a marketing and sales organisation in Europe Our Mission For Medical Information, Drug Safety Adverse Event Reports and/or Product Quality Complaints:

KEY FACTS ABOUT VIFOR PHARMA, INC.

Company name
VIFOR PHARMA, INC.
Status
Active
Filed Number
F15000005435
FEI Number
260893742
Date of Incorporation
December 9, 2015
Age - 9 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://relypsa.com
Phones
(650) 421-9500
(844) 735-9772
(844) 835-8277

VIFOR PHARMA, INC. NEAR ME

Principal Address
200 CARDINAL WAY,
REDWOOD CITY,
CA,
94063,
US

See Also

Officers and Directors

The VIFOR PHARMA, INC. managed by the two persons from Glattbrugg, REDWOOD CITY on following positions: Dire, President

Alex Sigalas

Position
Dire Active
From
Glattbrugg, , 9014

Molly Painter

Position
President Active
From
REDWOOD CITY, CA, 94063





Registered Agent is CT CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

March 2, 2021
AMENDMENT AND NAME CHANGE

Annual Reports

2023
April 18, 2023
2022
April 21, 2022